- SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level
Hua-Tao Wu et al, 2023, Epigenomics CrossRef - IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Xin Xu et al, 2022, Materials Today Bio CrossRef - Targeting IGF2BP3 in Cancer
Xin Liu et al, 2023, International Journal of Molecular Sciences CrossRef